1
of particular transcription factors, signal transducer and activator of transcription 3 1 (STAT3), is a member of the STAT protein family in response to LPS, cytokines, growth 2 factors etc. [14] . After stimulated by a ligand through its specific receptor (e.g. LPS 3 versus Toll like receptors (TLRs)), STAT3 located in cytoplasm is phosphorylated by 4 an adaptor protein, receptor-associated Janus kinases (JAK), and forms homo-or 5 heterodimers [14] . Activated STAT3 finally translocate to the compartment of the cell 6 nucleus where they serve as transcription activators and mediate a variety of gene 7 expressions in response to different cell stimuli [15] . Particularly, STAT3 is activated 8 until tyrosine 705 is phosphorylated in response to ligands such as interferons, 9 epidermal growth factor, IL-5, IL-6 etc. [14] .
In contrast to tyrosine 705 10 phosphorylation, STAT3 may also be activated via serine 727 phosphorylation by 11 mitogen-activated protein kinases [16] . Undoubtedly, STAT3 plays an essential role 12 in cellular processes in response to inflammation, cell growth and apoptosis [15] . 13
Targeted inhibition of JAK-STAT pathways, particularly STAT3, has been a potential 14 treatment strategy for obesity [17] , atherosclerosis [18] , prostate cancer, breast cancer 15 and hepatoma [19] . 16 studies [8, 24] , its anti-inflammatory mechanism via intracellular signaling pathways in 1 activated inflammatory macrophages were not fully understood. 2
To unravel the possible anti-inflammatory mechanism of Q, activated inflammatory 3 macrophages isolated from the peritoneal cavity of mice injected intraperitoneally (i.p.) 4 with LPS for 12 h were treated with Q for 3 h in vitro. For comparison with the effect 5 of Q, Q3G, a major metabolite of Q, was also selected to perform. Changes in gene 6 expression amounts of pro-/anti-inflammatory cytokines, such as TNF-α/IL-10, and 7 components of inflammation-related intracellular signaling pathways, including TLR2, 8 TLR4, NF-κB, JAK2 and STAT3, in the activated inflammatory macrophages were 9 measured using two-step reverse transcription (RT) and real-time quantitative 10 polymerase chain reaction (qPCR). Phosphorylation of the STAT3 protein in the 11 activated inflammatory macrophages was determined using an in-cell enzyme-linked 12 immuno-sorbent assay (ELISA) method. 
Sample preparation 17
Female BALB/cByJNarl mice (7- week-old) were provided by the National Laboratory 1 Animal Center, National Applied Research Laboratories, Ministry of Science and 2 Technology in Taipei, Taiwan, ROC, and maintained in the Department of Food Science 3
and Biotechnology at National Chung Hsing University, Taiwan, ROC. The mice 4
were housed in an animal room with a 12-h-light and 12-h-dark cycle, constant 5 temperature (23 ± 2 ℃) and relative humidity (50-75%). The experimental mice were 6 fed a laboratory standard diet (Diet MF 18, Oriental Yeast Co., Ltd., Osaka, Japan) and 7 free access to water ad libitum. After acclimatization for 1 week, the experimental 8 mice (8 weeks old) were randomly divided into two groups, including normal mice and 9
LPS-treated mice. The animal experiments used in the present study were reviewed 10 and approved by the Institutional Animal Care and Use Committee (IACUC), National 11 Chung Hsing University, Taiwan, ROC ( the experimental mice sacrificed to isolate normal or activated inflammatory macrophages, respectively [13, 25] . The mice were anaesthetized with isoflurane (cat. 1 no., 4900-1605, Panion & BF Biotech Inc., Taipei, Taiwan) using a vaporizer (CAS-2 01, Northern Vaporiser Limited, Cheshire, England, UK) and bled by retro-orbital 3 venous plexus puncture to collect blood. Then, the mice immediately sacrificed with 4 CO2 to isolate primary peritoneal macrophages.
Each mouse peritoneal cavity was 5 lavaged through peritoneum with 2 aliquots of 5 ml sterile Hank's balanced salts 6 solution (HBSS). The lavage fluid was collected and centrifuged at 4 ℃, 400 ×g for 7 10 min to harvest cell pellets. The cell pellets that are peritoneal macrophages (>90%) 8
were collected and re-suspended in tissue culture medium (TCM, a serum replacement; 9
Celox Laboratories Inc., Lake Zurich, IL). The peritoneal macrophages isolated from 10 each animal were adjusted to a density of 2 × 10 6 cells/ml in TCM medium with a 11 hemocytometer using the trypan blue dye exclusion method for following experiments. 12 13 2.4. Determination of an optimal incubation time for activated inflammatory 14 macrophages to express target cytokine genes 15
16
To determine the optimal incubation time for expressing target cytokine genes in 17 activated inflammatory macrophages, isolated activated inflammatory macrophages (2 18 ml/well) were cultured with TCM medium (2 ml/well) in 6-well plates to achieve a final 19 cell density of 1 × 10 6 cells/ml. The plates were incubated at 37 ℃ in a humidified 20 incubator with 5% CO2 and 95% air for 0, 3, 6, or 12 h, respectively. Throughout the 21 incubation, the plate was then centrifuged at 25℃, 400 × g for 10 min. The 22 supernatant was discarded and the cell pellet washed with 1 ml sterile PBS/well. The 23 cell pellet in the wells was collected to extract total RNA to analyze the gene expression 24 of pro-inflammatory cytokine (TNF-α) and anti-inflammatory cytokine (IL-10) using 1 expression profiles were selected as biomarkers for evaluating inflammation status in 2 the activated inflammatory macrophages.
Based on the target cytokine gene 3 expression profiles, incubation of normal or activated inflammatory macrophages with 4 samples for 3 h in vitro was selected as an optimal incubation time for the following 5 studies. 6 7
Effect of Q and Q3G on gene expression of target cytokines and components of 8 intracellular inflammation-related signaling pathway 9
In our previous study, Q or Q3G treatments lower than 50 μM could not result in any 11 cytotoxicity on mouse peritoneal macrophages in vitro [24] . Therefore, Q or Q3G at 12 20 and 50 μM were selected to treat isolated normal or activated inflammatory 13 macrophages to re-verify anti-inflammatory potential and further determine a possible 14 anti-inflammatory mechanism.
Isolated normal or activated inflammatory 15 macrophages (2 ml/well) were cultured with Q or Q3G (2 ml/well) at the indicated final 16 concentrations of 0, 20, and 50 μM in 6-well plates. Since glucocorticoid 17 dexamethasone (Dex) at 0.1 to 10 μM have been found to inhibit LPS-induced 18 inflammation in J774 macrophages in vitro [26], we chosen Dex at 1 μM as a positive 19 control for comparison. The plates were incubated at 37 ℃ in a humidified incubator 20 with 5% CO2 and 95% air for 3 h, and then centrifuged at 25℃, 400 × g for 10 min. 21
The supernatant was discarded and the cell pellet washed with 4 ml sterile PBS. The 22 cell pellet in the wells was used to extract total RNA using TRIzol reagent (Invitrogen, 23 CA, USA). The isolated RNA samples from the treated cells were stored at -80℃ for 24 future RT and real-time qPCR assay. Changes in the gene expression amounts of pro-25 inflammatory cytokine (TNF-α) and anti-inflammatory cytokine (IL-10) were selected 1 as indicators for evaluating the anti-inflammatory potential of Q or Q3G. Changes in 2 the gene expression amounts of intracellular inflammation-related signaling 3 components, including TLR2 and STAT3, were measured to determine possible anti-4 inflammatory mechanisms of Q or Q3G. 5 6 2.6. Targeted gene expression assays 7 8 2.6.1. Extraction and quality evaluation of total RNA from treated cells 9
The extraction method was performed as described previously [27, 28] . To evaluate 10 the quality of extracted total RNA, an aliquot of 2 μl of RNA solution was pipetted into An aliquot of 2 µg of total RNA isolated from the treated cells was pipetted into a clean 23 tube. To prevent DNA contamination, DNA in the RNA sample was digested using a 24 commercial kit of RQ1 RNase-Free DNase (Promega, Madison, WI, USA).
Then, 25 the first strand cDNA was produced from mRNA using a commercial kit of M-MLV 1
Reverse Transcriptase (Promega, Madison, WI, USA) which contains reaction buffer 2 (Promega, Madison, WI, USA), dNTP Mix 10 mM (Promega, Madison, WI, USA), and 3
Oligo dT (Invitrogen, CA, USA) in a total volume of 25 μl. The reaction of reverse 4 transcription was performed for one cycle with the following program using a PCR 5 thermal cycler machine (Genesis 96; Pebio Scientific Company, Taipei, Taiwan): 25°C 6 for 5 min, 42°C for 60 min, 70 °C for 15 min, and followed by cooling to 4°C. After 7 the first cDNA was completely synthesized, the single strand cDNA sample was diluted 8 10-fold (v/v) in nuclease-free water and then stored at -80 °C for use. 9 Sydney, Australia) using the following program: hot-start activation at 95 °C for 15 min, 20 followed by 40-50 cycles of denaturation at 95 °C for 30 s, annealing at 60 °C for 30 21 s, and extension at 72 °C for 30 s. The Ct (threshold cycle number) value of the target 22 gene expression was achieved according to fluorescence intensity measured using the 23 real-time rotary analyzer. Each biological determination was carried out in triplicate. 24
The comparative Ct method was used to quantify relative expression amounts of targeted mRNA species, indicating that a lower Ct value corresponds to a higher mRNA 1 expression amount [21] . The stably expressed mouse β-actin, a housekeeping gene, 2 was selected as a reference for calibration. Relative gene expressions of pro-3 inflammatory TNF-α and anti-inflammatory IL-10 cytokines, as well as components of 4 intracellular inflammation-related signaling, including TLR2 and STAT3 were measured. 5
Relative mRNA expression amounts in differently treated cells are expressed as the fold 6 change value. The expression ratio (R) of individual mRNA amount at treated vs. 7 control condition in the cells was determined using the equation: R = 2 -ΔΔCt [29, 30] . 8
The following equations were used to calculate each target gene expression (e.g., 9
cytokines or inflammation-related signaling) with respect to its control situation [31]: were measured using an in-cell ELISA method. STAT3 phosphorylation in normal or 20 activated inflammatory macrophages treated without or with Q were further measured 21
to clarify the role of STAT3 phosphorylation at tyrosine 705 in inflammation. Briefly, 22 normal or activated inflammatory macrophages (50 μl/well) were cultured in the 23 absence or presence of Q (50 μl/well) at the indicated final concentrations of 0, 20, and 24 and 95% air for 3 h. After incubation, the plate was centrifuged at 25 ℃, 400 × g for 1 10 min to remove the supernatant. The cell pellet was collected to measure STAT3 2 phosphorylation at tyrosine 705 using a STAT3 Colorimetric In-Cell ELISA Kit (Pierce 3
Biotechnology, Rockford, IL, USA). Data were calculated with the average A450 4 value for each experimental condition (e.g., with and without treatment) for each target. 5
For assessing STAT protein modification with treatment, the fold change as a ratio of 6 A450 values from the treated and non-treated modified protein were calculated. To determine the optimal incubation time of mouse primary activated inflammatory 2 macrophages for mRNA expression assays, the target cytokine mRNA expression in 3 the cells was analyzed. The results showed that relative expression of target cytokines 4 in mouse primary activated inflammatory macrophages, including TNF-α and IL-10 5 changed in a time-dependent manner ( Table 2 ). The relative expression level of TNF-6 α was significantly different at all incubation times (P < 0.05). The expression of the 7 pro-inflammatory cytokine TNF-α was dominant at the early stage (e.g., incubation for 8 3 h), while that of the anti-inflammatory cytokine IL-10 was dominant at the late stage 9 (e.g., incubation for 12 h), which indicates inhibition of the synthesis of pro-10 inflammatory cytokines during the inflammatory process. Thus, the highest fold 11 change in the ratio of pro-/anti-inflammatory cytokine gene expression (TNF-α/IL-10) 12 in mouse primary activated inflammatory macrophages was 6.89±1.88 at 3 h-incubation. 13
Based on the most significance (P < 0.05) of cytokine gene expression profile ( Table  14 2), the 3 h-incubation time was selected as optimal incubation time for the following 15 studies. 16 17
Effect of Q or Q3G in vitro on the cytokine gene expression profile of activated 18 inflammatory macrophages 19 20
To re-confirm the anti-inflammatory potential of Q based on pro-and anti-inflammatory 21 cytokine gene expression profile, the normal or activated inflammatory macrophages 22 were treated with Q or Q3G at the indicated non-toxic optimal concentrations (20 and 23 50 μM) for 3 h [24]. The results showed that treatments of normal macrophages (from 24 mice treated i.p. with PBS for 12 h) with Q at 20 μM significantly (P < 0.05) increased mRNA expression amounts of both TNF-α and IL-10, but could not significantly (P > 1 0.05) change the ratio of pro-/anti-inflammatory (TNF-α/IL-10) cytokine gene 2 expressions ( Table 3 ). Our results suggest that Q administration in vitro at the 3 indicated appropriate concentration of 20 μM might activate primary normal 4 macrophages by increasing the mRNA expressions of both pro-inflammatory (TNF-α) 5
and anti-inflammatory (IL-10) cytokines, but overall slightly decreased inflammation 6 status by decreasing the ratio of pro-/anti-inflammatory (TNF-α/IL-10) cytokine gene 7 expression. Importantly, treatment of activated inflammatory macrophages (from 8 mice treated i.p. with LPS for 12 h) with Q at either 20 or 50 μM significantly decreased 9
(P < 0.05) the mRNA expressions of TNF-α, but obviously increased those of IL-10 10 (Table 3) . Q administration at either 20 or 50 μM overall and significantly (P < 0.05) 11
inhibited the ratio of pro-/anti-inflammatory (TNF-α/IL-10) cytokine gene expressions 12 in activated inflammatory macrophages (Table 3 ). Our results evidence that Q exerts 13 substantive anti-inflammatory effects on activated inflammatory macrophages by 14 decreasing TNF-α mRNA expression amounts and ratios of pro-/anti-inflammatory 15
(TNF-α/IL-10) cytokine gene expressions, but increasing IL-10 mRNA expression 16 amounts. Interestingly, we found that Dex treatment effects on normal and activated 17 inflammatory macrophages in vitro were similar to those of Q, indicating that either 18
Dex or Q treatments had a therapeutic effect against inflammation. Corticosteroid-19
like Dex is already used in clinical treatments for anti-inflammatory medications even 20 though it may cause adverse side effects. Q administration for inflammation treatment 21 may be an alternative choice to replace or reduce the clinical use of Dex in the future. 22
Pharmacokinetic areas under the plasma concentration-time curves of daily oral 23 supplementation with Q (50-and 150-mg dosages, respectively) ranged from 76.1 24 μM·min to 305.8 μM·min in volunteers with no apparent toxicity, suggesting Q administration safety in vivo [32] . 1 After Q is assimilated by macrophages, it may be further metabolized into Q3G. To 2 compare anti-inflammatory potential of Q and Q3G, Q3G were also selected to treat 3 normal and activated inflammatory macrophages for 3 h. The results showed that 4 Q3G administration to normal macrophages in vitro significantly increased TNF-α, but 5 just slightly increased IL-10 gene expressions (Table 4 ). Moreover, Q3G significantly 6 (P < 0.05) increased the ratio of pro-/anti-inflammatory (TNF-α/IL-10) cytokine gene 7
expressions, suggesting that Q3G overall slightly increased inflammation status in 8 normal macrophages. Importantly, treatment of activated inflammatory macrophages 9
(from mice treated i.p. with LPS for 12 h) with Q3G at either 20 or 50 μM significantly 10 decreased (P < 0.05) the mRNA expressions of TNF-α, but obviously increased those 11 of IL-10 (Table 4) . Q3G administration at either 20 or 50 μM overall and significantly 12 (P < 0.05) inhibited the ratio of pro-/anti-inflammatory (TNF-α/IL-10) cytokine gene 13 expressions in activated inflammatory macrophages (Table 4 ). Our results evidence 14 that Q3G also exerts substantive anti-inflammatory effects on activated inflammatory 15 macrophages, but not normal macrophages, by decreasing TNF-α mRNA expression 16 amounts and ratios of pro-/anti-inflammatory (TNF-α/IL-10) cytokine gene expressions, 17 but increasing IL-10 mRNA expression amounts. 18
Dex is a glucocorticoid that has been widely used to treat many inflammatory and 19 autoimmune diseases including rheumatoid arthritis, bronchospasm, and idiopathic 20 thrombocytopenic purpura [33] . In the present study, we show that Dex has 21 therapeutic (curative) effects in activated inflammatory diseases by regulating cytokine 22 secretion profiles in inflammatory cells. Similar to Dex administration effects, Q and 23 Q3G in vitro administrations overall decreased inflammation status in activated 24 inflammatory macrophages (Tables 3 and 4 ). Q has been found to have diverse physiological effects, including antioxidant and anti-inflammatory effects in different 1 tissues [34,35]. Q3G is the major quercetin metabolite that is reported to have 2 antioxidant functions in vitro, and regulate coronary venous barrier function by 3 improving blood-borne inflammatory mediators in a novel microvascular wall model 4 [36] . In the present study, our results further suggest that Q and Q3G treatments in 5 vitro might have an immuno-stimulatory effect on normal macrophages, but inhibit 6 inflammation status in activated inflammatory macrophages by regulating cytokine 7 gene expressions (Tables 3 and 4 ). However, Q3G was found to have a lower anti-8 inflammatory effect on normal macrophages than Q in this experimental model. We 9
hypothesize that the glycoside moiety in Q3G improves its water solubility, but 10 decreases its uptake by macrophages [37] . The uptake and metabolism of Q in mouse 11 primary macrophages have been previously described in our report [4] . Obviously, Q 12 has the better effect against inflammation than that of Q3G in both and normal and 13 activated inflammatory macrophages.
To more accurately describe the anti-14 inflammatory mechanism of Q, it was further applied to normal and activated 15 inflammatory macrophages for analyzing inflammation-related intracellular signaling 16 pathways. 17 18
Effect of Q administration in vitro on relative gene expression amounts of 19
components of inflammation-related intracellular signaling pathway in normal or 20 activated inflammatory macrophages 21 Table 5 shows the in vitro effects of Q on relative gene expression amounts of 23 components of inflammation-related intracellular signaling pathway, including TLR2, 24 TLR4, NF-κB, JAK2, and STAT3, in normal or activated inflammatory macrophages.
The results showed that Q administration more or less increased TLR2, TLR4, NF-κB, 1 JAK2, and STAT3 gene expression amounts compared to those of controls in normal 2 macrophages ( Table 5 ). In general, cultured primary macrophages that were isolated 3 from the body may result in slight spontaneous inflammation due to the change of 4 oxygen content in the environment.
However, our results suggest that Q 5 administration at 50 μM might inhibit spontaneous inflammation in normal 6 macrophages via inhibiting the TLR2 signaling pathway.
The physiological 7 significance of increased NF-κB and STAT3 gene expression amounts induced by Q 8 might result from the immune-stimulatory property of Q and remains to be further 9 studied. In addition, we found that TLR2 and NF-κB gene expression amounts 10 significantly (P < 0.05) increased, but JAK2 and STAT3 gene expression amounts 11 significantly decreased in activated inflammatory macrophages as compared to those 12 in normal macrophages ( Table 5 ). Our results suggest that mice treated with LPS i.p. dependently, and improved inflammation damage to activated inflammatory 20 macrophages by increasing JAK2 and STAT3 gene expressions that were hindered in 21 the activated inflammatory macrophages ( Table 5 ). The physiological significance of 22 increased NF-κB and JAK2 gene expression in the activated inflammatory macrophages 23 by Q administration remains to be further investigated. It was found that purified (Table 5 ). Moreover, our results showed 7 that STAT3 gene expression in both normal and activated inflammatory macrophages 8 were significantly increased by Q administration at appropriate concentrations in vitro 9
as compared to those of the controls (P < 0.05). Undoubtedly, STAT3 gene expression 10 and activation influenced by Q plays an important role in inflammation. Thus, the 11 possible mechanism of STAT3 activation through phosphorylation of STAT3 protein at 12 tyrosine 705 was further measured in the present study. phosphorylation at tyrosine 705 were measured using an in-cell ELISA method. 21 Figure 1 shows Q in vitro administration effects on STAT3 phosphorylation at tyrosine 22 705 in normal or activated inflammatory macrophages. The results showed that 23 STAT3 protein phosphorylation at tyrosine 705 in activated inflammatory macrophages 24 significantly (P < 0.05) increased compared to that of normal control (Fig. 1) , indicating that LPS administration i.p. induced STAT3 phosphorylation in the activated 1 inflammatory macrophages. Most importantly, Q in vitro administration at 20 μM 2 significantly (P < 0.05) inhibited STAT3 phosphorylation at tyrosine 705 in the 3 activated inflammatory macrophages, but did not significantly (P > 0.05) influence 4 normal macrophages. Our results suggest that Q administration might inhibit 5 inflammation status in the activated inflammatory macrophages by inhibiting the 6 signaling pathway involved in phosphorylation of STAT3 at tyrosine 705. However, 7
Dex treatment in vitro could not significantly (P > 0.05) change phosphorylation levels 8 of STAT3 protein at tyrosine 705 in both normal and activated inflammatory 9 macrophages (P > 0.05). 10
The present study indicates that Q administration inhibits the inflammation status in 11 activated inflammatory macrophages via regulation of cytokine gene expression. This 12 effect is mediated by decreased gene expressions of pro-inflammatory cytokine TNF-α 13 but increased anti-inflammatory cytokine IL-10 (Table 3 ).
In addition, Q 14 administration in vitro ameliorated the inflammation-induced injury in the activated 15 inflammatory macrophages by decreasing TLR2 gene expression in a dose-dependent 16 manner and by increasing that of JAK2 and STAT3 genes, which had been suppressed 17 in the activated inflammatory macrophages ( Table 5 ). Although STAT3 gene 18 expression increased with Q administration, STAT3 phosphorylation at tyrosine 705 in 19 activated inflammatory macrophages (which was increased by LPS treatment i.p.) was 20 inhibited (Fig. 1) . It was found that Q or its metabolites could enter macrophages to 21 exert their anti-inflammatory functions [5] .
In the present study, we further 22 determined the effects of Q administration in vitro on components of inflammation-23 related signaling pathway (TLR2 and TLR4) in activated inflammatory macrophages. 24
In addition, we infer that increased NF-κB expression might inhibit STAT3 expression 25 in the activated inflammatory macrophages in the absence of Q (Table 5 ). Both NF-1 κB and STAT3 are transcription factor in cells. Interestingly, Q administration seemed 2 to simultaneously increase both NF-κB and STAT3 gene expression in normal and 3 activated inflammatory macrophages ( Table 5 ). The relationship between STAT3 and 4 NF-κB gene expression influenced by Q remains to be further clarified. 5
Some achievements have been obtained in the present study, and Q may be further 6 applied for anti-inflammatory clinical use including tumor therapy [9, 14, 18, 39, 40] . 7
However, there are limitations in the present study. Firstly, this is still an ex vivo study; 8 therefore confirmation of the key findings in vivo using peritoneal challenge model 9
should be performed in the future. The findings with the murine cells may not be 10 recapitulated in the human cells. Unfortunately, changes of TLR and NF-κB protein 11 levels in the cells were not determined so that the findings impact at the protein level 12 could not be confirmed. It remains unclear why Q increased the gene expression of 13 STAT3, but inhibited its phosphorylation. However, our results are the first report to 14 suggest that Q inhibits LPS-induced inflammation ex vivo through suppressing TLR2 15 gene expression and STAT3 phosphorylation in activated inflammatory macrophages. 16 17
Conclusion 18 19
This study evidenced that Q and its metabolite Q3G decreased TNF-α gene expression 20 amounts and ratios of pro-/anti-inflammatory (TNF-α/IL-10) cytokine gene expressions, 21 but increased IL-10 gene expression amounts in activated inflammatory macrophages. 22
However, Q3G has similar, but lower, effects on activated inflammatory macrophages. Table 3 Effects of quercetin administration on cytokine gene expression in activated peritoneal macrophages from female BALB/c mice intraperitoneally injected with phosphatebuffered saline or lipopolysaccharide at 8 mg/kg BW through 12 h. a, b, c .
Gene

Macrophages control
Quercetin (μM) Dex
(1 μM) 20 50
Relative expression amount (fold)
TNF inflammatory 1.00 ± 0.00 A 0.00 ± 0.00 BC 0.00 ± 0.00 B 0.00 ± 0.00 C a Values are means ± SEM (n = 5 biological determinations), analyzed using one-way ANOVA, followed by Duncan's new multiple range test. b Values within same row not sharing a common superscript capital letter are significantly different (P < 0.05) from each other. c The collected peritoneal macrophages were cultured with quercetin-3glucuronide or dexamethasone (Dex, a positive control) for 3 h in vitro.
Table 5
Effects of quercetin administrations on relative gene expression folds of components in the inflammation-related signaling pathway in normal and inflammatory macrophages from female BALB/c mice intraperitoneally injected with phosphatebuffered saline or lipopolysaccharide at 8 mg/kg BW through 12 h. a, b, c, d .
Gene Macrophages
Quercetin ( Fig. 1 
Figure legends
